Equal-WT
WhaleScore 2.0
?
Artal Group S.a. is based out of Luxembourg. Their last reported 13F filing for Q4 2023 included $3,008,088,000 in managed 13F securities
and a top 10 holdings concentration of 75.26%. Artal Group S.a.'s largest holding is Cava Group Inc with shares held of 32,007,990. Whalewisdom has at least 47 13F filings, 6 13G filings, and 22 Form 4 filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
SRRK Scholar Rock Holding | 4.28% |
ARGX Argenx SE ADS ADR | 1.47% |
KYMR Kymera Therapeutics, | 1.07% |
ARWR Arrowhead Pharmaceut | 1.04% |
FOLD Amicus Therapeutics (CALL) | 0.92% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
MRTX Mirati Therapeutics | 3.78% |
CERE Cerevel Therapeutics | 1.53% |
RVMD Revolution Medicines | 1.39% |
FOLD Amicus Therapeutics | 1.16% |
IMGN ImmunoGen Inc. | 1.03% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
CAVA Cava Group Inc | 45.73% |
SRRK Scholar Rock Holding | 7.04% |
LXRX Lexicon Pharmaceutic | 5.98% |
CYTK Cytokinetics Inc | 3.37% |
APLS Apellis Pharmaceutic | 2.83% |
The Reporting Manager does not have formal investment discretion with respect to all of the securities in the indicated rows in the Form 13F Information Table, but may be deemed to be part of a group exercising such investment discretion. Such group, if any, would include the managers identified in the column captioned "Other Managers" relating to a given issuer. The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, or for any other purpose, that the Reporting Manager or any Other Manager exercises investment discretion or is a member of such a group with respect to such securities. Reference is made to reports filed under Sections 13(d), 13(g), and 16(a) for additional information with respect to such beneficial ownership and/or pecuniary interest of the Reporting Manager, any Other Manager and related entities.
2023-12-31
13F Activity
Market Value | $3.01b, Prior: $2.33b |
New Purchases | 16 stocks |
Added To | 18 stocks |
Sold out of | 23 stocks |
Reduced holdings in | 27 stocks |
Top 10 Holdings % | 75.26% |
Turnover %[1] | 40.63% |
Turnover Alt %[2] | 9.99% |
Time Held Top 20 | 6.8 quarters |
Time Held Top 10 | 5.1 quarters |
Time Held All | 9.47 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31